Table 3.
Description of prone positioning cycles and complications
| All cyclesn=302 (100%) |
Standard pronationn=227 (75%) |
Extended pronationn=75 (25%) |
p.Value | ||
|---|---|---|---|---|---|
| COVID-19 Wave | first | 144 (48%) | 143 (63%) | 1 (2%) | <0.0001 |
| second | 158 (52%) | 84 (37%) | 74 (98%) | ||
| Veno-Venous ECMO (yes) | 36 (16%) | 30 (16%) | 6 (14%) | 0.734 | |
| Norepinefrine infusion – (yes) | 120 (48%) | 91 (51%) | 29 (39%) | 0.077 | |
| Norepinephrine dosage (mcg/Kg/min) | 0.06 (0.04-0.07) | 0.06 (0.04-0.08) | 0.04 (0.03-0.07) | 0.007 | |
| Dopamine infusion – (yes) | 53 (23%) | 42 (26%) | 11 (16%) | 0.088 | |
| Dopamine dosage (mcg/Kg/min) | 4.1 (2.35 - 5.19) | 4.1 (2.3-5.26) | 3.07 (2.42-5.00) | 0.080 | |
| Medical device displacement | Endotracheal tube n= (%) | 1 (0.5%) | 1 (0.5%) | 0 (0%) | 0.565 |
| Nasogastric Tube n= (%) | 2 (1%) | 2 (1%) | 0 (0%) | 0.455 | |
| Vascular catheters n=(%) | 0 (0%) | 0 (0%) | 0 (0%) | --- | |
| Hemodynamic instability - n=(%) | 29 (10%) | 22 (10%) | 7 (9%) | 0.927 | |
| Prolonged Arterial Desaturation - n=(%) | 57 (19%) | 45 (20%) | 12 (16%) | 0.463 | |
| Bronchial secretions retention - n=(%) | 33 (11%) | 26 (12%) | 7 (9%) | 0.610 | |
| Vomit – n=(%) | 0 (100%) | 0 (0%) | 0 (0%) | --- |